Abstract: [Objective] To introduce the surgical technique and its preliminary clinical outcomes of the sandwich bone grafting for bone defect secondary to curettage of the distal femoral giant cell tumor. [Methods] From January 2016 to December 2024, a total of 25 patients received this surgical treatment for bone giant cell tumor of the distal femur. After the patients were anesthetized, they were placed in a 30° supine position on the affected side. The surgical exposure was carried out along the lateral intermuscular space to the bone surface of the femur. A bone fenestration was made with an electric drill, and the entire lesion was exposed as much as possible within the visual field. The tumor was thoroughly removed with curettes in sequence. The tumor wall was cauterized at a high temperature by electrocoagulation, and then was polished with a high-speed burr with the articular cartilage and the outer subchondral bone preserved intact. A suitable femoral plate was pre-placed and fixed on one side with a screw, while the remaining screws measured in length. The artificial bone material was evenly placed on the the articular side in a layer with thickness of 10~15 mm, then, gelatin sponge was placed, and finally bone cement was poured into the remaining tumor cavity. The inactivated bone fragments harvested from fenestration were replanted, the preplaced plate was positioned correctly, and the screws were sequentially tightened for fixation before the bone cement solidified. The knee joint was flexed and extended to exclude the overflow of bone cement into the joint cavity. [Results] All patients had the surgical procedures performed successfully, and were followed up ranging from 6 to 84 months. The average distance between the distal end of the plate and the articular surface of the femur on the postoperative X-ray in the anteroposterior position was ranged from 0 mm to 56mm with a mean of (13.0± 2.5) mm, with the average healing time of bone graft ranged from 13 weeks to 22 weeks in a mean of (17.6±4.2) weeks. At the latest followup, the Musculoskeletal Tumor Society (MSTS) was of (26.0±3.2) (ranging from 21 to 30 points). Regarding adverse events, 4 cases were of local recurrence, 1 case of severe lameness, and 2 cases of local rejection after the operation, however, no infection, deep vein thrombosis of the lower limb and other complication were noted in anyone of them. [Conclusion] The sandwich bone grafting for the distal femoral bone giant cell tumor is technically feasible, provides immediate stability and increases the success rate of joint preservation, and achieves satisfactory preliminary clinical consequence.